Literature DB >> 1560532

Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.

W A Alexander1, B Moss, T R Fuerst.   

Abstract

The gene encoding bacteriophage T7 RNA polymerase (T7gene1) was placed under the control of regulatory elements from the Escherichia coli lac operon to construct an inducible vaccinia virus expression system consisting entirely of prokaryotic transcriptional machinery. Regulated expression of T7 RNA polymerase was necessary to construct a stable recombinant vaccinia virus harboring a T7 promoter; otherwise, uncontrolled expression led to interference with endogenous virus replication. To this end, the gene encoding the repressor protein of the lac operon was fused to a viral early/late promoter so that it was expressed constitutively, and the lac operator was interposed between a viral major late promoter and T7gene1. Greater than 99% repression of T7 RNA polymerase, which was relieved approximately 80-fold in the presence of the inducer isopropyl-beta-D-thiogalactopyranoside (IPTG), was obtained. An expression cassette containing a T7 promoter-controlled beta-galactosidase reporter gene was recombined into a different region of the viral genome containing T7gene1. A stable, double recombinant virus was isolated and grown to a high titer. In the absence of inducer, beta-galactosidase expression was substantially repressed. Addition of increasing amounts of IPTG induced expression of beta-galactosidase to the point of suppression of viral replication. This hybrid vaccinia virus system (Vac/Op/T7) has potential applications for the efficient bioproduction of a wide variety of gene products.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560532      PMCID: PMC241052     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Product review. New mammalian expression vectors.

Authors:  B Moss; O Elroy-Stein; T Mizukami; W A Alexander; T R Fuerst
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

2.  Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor.

Authors:  U Deuschle; R Pepperkok; F B Wang; T J Giordano; W T McAllister; W Ansorge; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Non-producer human cells induced by murine sarcoma virus.

Authors:  J S Rhim; H Y Cho; R J Huebner
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

4.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Targeting bacteriophage T7 RNA polymerase to the mammalian cell nucleus.

Authors:  J J Dunn; B Krippl; K E Bernstein; H Westphal; F W Studier
Journal:  Gene       Date:  1988-09-07       Impact factor: 3.688

6.  Nucleotide sequence of the cloned gene for bacteriophage T7 RNA polymerase.

Authors:  S J Stahl; K Zinn
Journal:  J Mol Biol       Date:  1981-06-05       Impact factor: 5.469

7.  Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.

Authors:  T R Fuerst; P L Earl; B Moss
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

8.  Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells.

Authors:  O Elroy-Stein; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

9.  Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader.

Authors:  T R Fuerst; B Moss
Journal:  J Mol Biol       Date:  1989-03-20       Impact factor: 5.469

10.  Transfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vector.

Authors:  T R Fuerst; M P Fernandez; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  102 in total

1.  Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains.

Authors:  A L Edinger; C Blanpain; K J Kunstman; S M Wolinsky; M Parmentier; R W Doms
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

3.  Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.

Authors:  A L Edinger; M Ahuja; T Sung; K C Baxter; B Haggarty; R W Doms; J A Hoxie
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.

Authors:  A D Garcia; B Moss
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.

Authors:  Terri G Edwards; Stéphanie Wyss; Jacqueline D Reeves; Susan Zolla-Pazner; James A Hoxie; Robert W Doms; Frédéric Baribaud
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.

Authors:  Jacqueline D Reeves; Stephen A Gallo; Navid Ahmad; John L Miamidian; Phoebe E Harvey; Matthew Sharron; Stefan Pohlmann; Jeffrey N Sfakianos; Cynthia A Derdeyn; Robert Blumenthal; Eric Hunter; Robert W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

8.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

9.  Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.

Authors:  Rafal J Zielinski; Jeremy V Smedley; Pin-Yu Perera; Peter M Silvera; Thomas A Waldmann; Jacek Capala; Liyanage P Perera
Journal:  Vaccine       Date:  2010-08-20       Impact factor: 3.641

10.  Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4.

Authors:  Desyree Murta Jesus; Nissin Moussatche; Baron B D McFadden; Casey Paulasue Nielsen; Susan M D'Costa; Richard C Condit
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.